Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 15/20 | 0.40 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.40 |
| ▸ | MME | P08473 | 4/20 | 0.37 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.37 |
| ▸ | FAP | Q12884 | 1/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.37 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | MMEL1 | Q495T6 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15108795 | 1.00 | DPP4 (0.40) | DPP4PIN1MMEDPP7FAP | |
| SCHEMBL15103376 | 1.00 | DPP4 (0.40) | DPP4PIN1MMEDPP7FAP | |
| SCHEMBL2572967 | 0.85 | DPP4 (0.44) | DPP4DPP7FAPDPP8DPP9 | |
| SCHEMBL30136577 | 0.85 | DPP4 (0.44) | DPP4DPP7FAPDPP8DPP9 | |
| SCHEMBL12971210 | 0.85 | DPP4 (0.44) | DPP4DPP7FAPDPP8DPP9 | |
| SCHEMBL3705644 | 0.85 | DPP4 (0.44) | DPP4PIN1MMECYP3A4MMEL1 | |
| SCHEMBL28306443 | 0.85 | PIN1 (0.43) | DPP4PIN1MMEDPP7DPP8 | |
| SCHEMBL28306442 | 0.85 | PIN1 (0.43) | DPP4PIN1MMEDPP7DPP8 | |
| SCHEMBL16750215 | 0.84 | DPP4 (0.42) | DPP4PIN1DPP7DPP8DPP9 | |
| SCHEMBL743044 | 0.84 | DPP4 (0.42) | DPP4PIN1DPP7DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023021529-A1 | IMPROVED ENZYMATIC SYNTHESIS OF SITAGLIPTIN OR ITS SALTS THEREOF | FERMENTA BIOTECH LIMITED (IN) | 2023-02-23 | — | — | WO | disclosed |